These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26979250)

  • 1. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
    van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
    Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery and formulations.
    Breitkreutz J; Boos J
    Handb Exp Pharmacol; 2011; 205():91-107. PubMed ID: 21882107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.
    Spomer N; Klingmann V; Stoltenberg I; Lerch C; Meissner T; Breitkreutz J
    Arch Dis Child; 2012 Mar; 97(3):283-6. PubMed ID: 22253279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
    Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
    J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
    Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
    J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
    Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
    Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
    Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
    Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods of administering oral formulations and child acceptability.
    van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
    Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
    Strickley RG
    J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate oral formulations and information in paediatric trials.
    Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C
    Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric drugs--a review of commercially available oral formulations.
    Strickley RG; Iwata Q; Wu S; Dahl TC
    J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
    Klingmann V
    AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral formulation of choice for children].
    Lajoinie A; Henin E; Kassai B
    Arch Pediatr; 2015 Aug; 22(8):877-85. PubMed ID: 26141805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of different oral formulations in infants and preschool children.
    van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
    Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.